AGP Executive Report
Last update: 3 hours agoPsoriasis Care Update: A narrative review highlights how nutrition, exercise, weight management, and mental health support can complement drug treatment for psoriasis. NHS Patient Safety: Scotland’s patient safety commissioner says some NHS culture is “nothing to see here,” with concerns about ventilation issues and patients being dismissed. Medication Safety & Accountability: ASHP and APhA back a “just culture” approach after reported harm from a medication error, stressing system fixes over blame. Overdose Prevention: Naloxone (Narcan) is framed as a “second-chance” medicine for opioid overdoses, with clear call-911 guidance. AI Regulation: The FDA seeks public feedback on how to regulate generative AI-enabled medical devices, including risk and postmarket monitoring. Medicaid Shockwaves: Kansas’ CareArc warns new federal eligibility rules could cut full Medicaid benefits for some immigrants starting Oct. 1. Sports Medicine Note: Bayern Munich says Jamal Musiala’s collapses followed a change in his treatment plan. Healthcare Access: SEARHC opens a new compounding pharmacy in Alaska’s Mendenhall Valley after years without one.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
![<![CDATA[Rezūm shows greater 1-year BPH symptom relief vs pharmacotherapy]]>](https://cdn.sanity.io/images/0vv8moc6/urologytimes/5096081e740a99a1a9a6c594ec610fa496eee079-653x367.png)
